Impact of hemostatic gene single point mutations in patients with non-diabetic coronary artery disease

Molecular Biology Reports

Volumn 36, Issue 8, 2009, Pages 2235-2243

  Var, Ahmet ^a   Ütük, Ozan ^a   Akçalı, Sinem ^a   Şanlıdağ, Tamer ^a   Uyanık, Bekir S ^a   Dinç, Gönül ^a  

^a CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Coronary artery disease; Hemostatic genes; Polymorphism; Single point mutation

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOGEN; FIBRINOGEN B BETA CHAIN; GLYCOPROTEIN IIIA; LEUCINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; UNCLASSIFIED DRUG; VALINE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON DIABETIC CORONARY ARTERY DISEASE; POINT MUTATION;

EID: 70350339758     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-008-9439-5     Document Type: Article

References (54)

1. MA Nordlie LE Wold RA Kloner 2005 Genetic contributors toward increased risk for ischemic heart disease J Mol Cell Cardiol 39 667 679 10.1016/j.yjmcc.2005.06.006 10.1016/j.yjmcc.2005.06.006 1:CAS:528: DC%2BD2MXhtVensr3I 16087188 (Pubitemid 41331055)
2. Atherosclerosis, thrombosclerosis and vascular biology Italian study group (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age Circulation 107 1117 1122 10.1161/01.CIR.0000051465.94572.D0 10.1161/01.CIR.0000051465. 94572.D0 (Pubitemid 36297202)
3. T Pastinen M Perola P Niini J Terwilliger V Salomaa E Vartiainen L Peltonen A Syvänen 1998 Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population Hum Mol Genet 7 1453 1462 10.1093/hmg/7.9.1453 10.1093/hmg/7.9.1453 1:CAS:528:DyaK1cXmtVSltLY%3D 9700201 (Pubitemid 28429927)
4. S Uitte de Willige MC de Visser JJ Houwing-Duistermaat FR Rosendaal HL Vos RM Bertina 2005 Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma levels Blood 106 4176 4183 10.1182/blood-2005-05-2180 10.1182/blood-2005-05-2180 1:CAS:528:DC%2BD2MXhtlaltr3E 16144795 (Pubitemid 41775924)
5. S Duga R Asselta E Santagostino S Zeinali T Simonic M Malcovati PM Mannucci ML Tenchini 2000 Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion Blood 95 1336 1341 1:CAS:528:DC%2BD3cXhtFKit7s%3D 10666208
6. DA Lane PJ Grant 2000 Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease Blood 95 1517 1532 1:CAS:528:DC%2BD3cXhsVGgt74%3D 10688804
7. KG Mann M Kalafatis 2003 Factor V: a combination of Dr Jekyll and Mr Hyde Blood 101 20 30 10.1182/blood-2002-01-0290 10.1182/blood-2002-01-0290 1:CAS:528:DC%2BD3sXhtFSrtQ%3D%3D 12393635 (Pubitemid 36025882)
8. GS Zaatari ZK Otrock AS Sabbagh RA Mahfouz 2006 Prevalence of factor V R2 (H1299R) polymorphism in the Lebanese population Pathology 38 442 444 10.1080/00313020600922934 10.1080/00313020600922934 1:CAS:528:DC%2BD28XhtlCiurbO 17008284 (Pubitemid 44477594)
9. D Mohanty K Ghosh A Khare 2004 Kulkarni. Thrombophilia in coronary artery disease: a double jeopardy B Indian J Med Res 120 13 23 1:CAS:528: DC%2BD2cXns1Gms7c%3D
10. E Castoldi JM Brugge GA Nicolaes D Girelli G Tans J Rosing 2004 Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations Blood 103 4173 4179 10.1182/blood-2003-10-3578 10.1182/blood-2003-10-3578 1:CAS:528:DC%2BD2cXkvVyit7w%3D 14976057 (Pubitemid 38685359)
11. M Margaglione A Bossone D Coalizzo G D'Andrea V Brancaccio A Ciampa E Grandone MGFV Di 2002 HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile Thromb Haemost 87 32 36 1:CAS:528:DC%2BD38XhtV2jurg%3D 11848454
12. RA Ariens TS Lai JW Weisel CS Greenberg PJ Grant 2002 Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms Blood 100 743 754 10.1182/blood.V100.3.743 10.1182/blood.V100.3.743 1:CAS:528: DC%2BD38XlvVCltr0%3D 12130481 (Pubitemid 34832596)
13. PS Wells JL Anderson DK Scarvelis SP Doucette F Gagnon 2006 Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis Am J Epidemiol 164 101 109 10.1093/aje/kwj179 10.1093/aje/kwj179 16740590 (Pubitemid 43992174)
14. A Elbaz O Poirier S Canaple F Chédru F Cambien P Amarenco 2000 The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction Blood 95 586 591 1:CAS:528:DC%2BD3cXlsFGhsQ%3D%3D 10627467
15. D Gemmati F Federici G Campo S Tognazzo ML Serino M De Mattei M Valgimigli P Malagutti G Guardigli P Ferraresi F Bernardi R Ferrari GL Scapoli L Catozzi 2007 Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients Mol Med 13 112 120 10.2119/2006-00049.Gemmati 10.2119/2006-00049.Gemmati 1:CAS:528: DC%2BD2sXmt12rsbw%3D 17515963 (Pubitemid 46786840)
16. RA Ariens H Philippou C Nagaswami JW Weisel DA Lane PJ Grant 2000 The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure Blood 96 988 995 1:CAS:528: DC%2BD3cXltlKitb8%3D 10910914
17. AJ Catto HP Kohler J Coore MW Mansfield MH Stickland PJ Grant 1999 Association of a common polymorphism in the factor XIII gene with venous thrombosis Blood 93 906 908 1:CAS:528:DyaK1MXpsFyisA%3D%3D 9920839
18. R González-Conejero I Fernández-Cadenas JA Iniesta J Marti- Fabregas V Obach J Alvarez-Sabín V Vicente J Corral J Montaner Proyecto Ictus Research Group 2006 Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients Stroke 37 2288 2293 10.1161/01.STR.0000236636.39235.4f 16857944 (Pubitemid 44337171)
19. C Russo D Girelli O Olivieri P Guarini F Manzato F Pizzolo B Zaia A Mazzucco R Corrocher 2001 G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease Circulation 103 2436 2440 1:CAS:528:DC%2BD3MXks1Khurw%3D 11369682
20. SR Poort FR Rosendaal PH Reitsma RM Bertina 1996 A common genetic variation in the 39-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 3698 3703 1:CAS:528:DyaK28XntVahsLg%3D 8916933
21. D Nagaraja TP Kruthika-Vinod R Christopher 2007 The prothrombin gene G20210A variant and puerperal cerebral venous and sinus thrombosis in South Indian women J Clin Neurosci 14 635 638 10.1016/j.jocn.2006.05.001 10.1016/j.jocn.2006.05.001 1:CAS:528:DC%2BD2sXlvV2qu7o%3D 17433691 (Pubitemid 46783489)
22. A Gilchrist N Solomon D Erickson A Sikand KA Bauer MS Kruskall O Kocher 2001 Automated detection of the G20210A prothrombin mutation using the LCx microparticle enzyme immunoassay Clin Chim Acta 314 249 254 10.1016/S0009- 8981(01)00655-6 10.1016/S0009-8981(01)00655-6 1:CAS:528:DC%2BD3MXosFKktrY%3D 11718704 (Pubitemid 33079207)
23. AT Tinmouth E Semple N Shehata DR Branch 2006 Platelet immunopathology and therapy: a Canadian Blood Services Research and Development Symposium Transfus Med Rev 20 294 314 10.1016/j.tmrv.2006.05.008 10.1016/j.tmrv.2006.05. 008 17008167 (Pubitemid 44467851)
24. M Laule I Cascorbi V Stangl C Bielecke KD Wernecke PM Mrozikiewicz SB Felix I Roots G Baumann K Stangl 1999 A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study Lancet 353 708 712 10.1016/S0140-6736(98)07257-2 10.1016/S0140-6736(98)07257-2 1:STN:280:DyaK1M7ntFGhsw%3D%3D 10073513 (Pubitemid 29103804)
25. M Sajid KV Vijayan S Souza PF Bray 2002 PlA polymorphism of integrin beta 3 differentially modulates cellular migration on extracellular matrix proteins Arterioscler Thromb Vasc Biol 22 1984 1989 10.1161/01.ATV.0000043664.48689.7F 10.1161/01.ATV.0000043664.48689.7F 1:CAS:528:DC%2BD38Xpt1Chs7c%3D 12482823 (Pubitemid 36025203)
26. NA Watkins E Schaffner-Reckinger DL Allen GJ Howkins NH Brons GA Smith P Metcalfe MF Murphy N Kieffer WH Ouwehand 2002 HPA-1a phenotype-genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta 3 integrin that disrupts the HPA-1a epitope Blood 99 1833 1839 10.1182/blood.V99.5.1833 10.1182/blood.V99.5.1833 1:CAS:528:DC%2BD38XhvFyqu7k%3D 11861302 (Pubitemid 34533060)
27. J Blasiak B Smolarz 2000 Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer Acta Biochim Pol 47 191 199 1:CAS:528:DC%2BD3cXktVOrt7g%3D 10961693
28. D Bucková L Izakovicová Hollá J Vácha 2002 Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population Allergy 57 446 448 10.1034/j.1398-9995.2002.03582.x 10.1034/j.1398-9995.2002.03582.x 11972486 (Pubitemid 34442160)
29. F Burzotta L Iacoviello A Di Castelnuovo R Zamparelli A D'Orazio C Amore R Schiavello MB Donati A Maseri G Possati F Andreotti 2003 4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study J Thromb Thrombolysis 16 149 154 10.1023/B:THRO.0000024052. 79415.62 10.1023/B:THRO.0000024052.79415.62 1:CAS:528:DC%2BD2cXjtFaksbc%3D 15087600 (Pubitemid 39137439)
30. P Leopardi F Marcon S Caiola A Cafolla E Siniscalchi A Zijno R Crebelli 2006 Effects of folic acid deficiency and MTHFR C677T polymorphism on spontaneous and radiation-induced micronuclei in human lymphocytes Mutagenesis 21 327 333 10.1093/mutage/gel031 10.1093/mutage/gel031 1:CAS:528: DC%2BD28XhtVOmurzN 16950805 (Pubitemid 44546416)
31. E Dagan R Brik Y Broza R Gershoni-Baruch 2006 Henoch-Schonlein purpura: polymorphisms in thrombophilia genes Pediatr Nephrol 21 1117 1121 10.1007/s00467-006-0155-x 10.1007/s00467-006-0155-x 16791607 (Pubitemid 44083884)
32. N Ihlemann C Rask-Madsen L Køber C Torp-Pedersen 2004 Vascular insulin response is preserved in non-diabetic patients with coronary artery disease, despite endothelial dysfunction Scand Cardiovasc J 38 22 27 10.1080/14017430310016397 10.1080/14017430310016397 1:CAS:528: DC%2BD2cXjtFCnsL8%3D 15204243 (Pubitemid 38455870)
33. RA DeFronzo E Ferrannini 1991 Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 14 173 194 10.2337/diacare.14.3.173 10.2337/diacare.14.3.173 1:STN:280:DyaK3M3ls1ymsw%3D%3D 2044434
34. Q Wang 2005 Molecular genetics of coronary artery disease Curr Opin Cardiol 20 182 188 10.1097/01.hco.0000160373.77190.f1 10.1097/01.hco.0000160373. 77190.f1 15861005 (Pubitemid 40704874)
35. B Mayer J Erdmann H Schunkert 2007 Genetics and heritability of coronary artery disease and myocardial infarction Clin Res Cardiol 96 1 7 10.1007/s00392-006-0447-y 10.1007/s00392-006-0447-y 17021678 (Pubitemid 46175364)
36. I Splawski J Shen KW Timothy GM Vincent MH Lehmann MT Keating 1998 Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1 Genomics 51 86 97 10.1006/geno.1998.5361 10.1006/geno.1998.5361 1:CAS:528:DyaK1cXltFegsrc%3D 9693036 (Pubitemid 28373376)
37. H Watkins WJ McKenna L Thierfelder HJ Suk R Anan A O'Donoghue P Spirito A Matsumori CS Moravec JG Seidman, et al. 1995 Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy N Engl J Med 332 1058 1064 10.1056/NEJM199504203321603 10.1056/NEJM199504203321603 1:CAS:528:DyaK2MXlslCnsrw%3D 7898523
38. KE Zerba RE Ferrell CF Sing 1998 Genetic structure of five susceptibility gene regions for coronary artery disease: disequilibria within and among regions Hum Genet 103 346 354 10.1007/s004390050828 10.1007/s004390050828 1:CAS:528:DyaK1cXmtFegu7w%3D 9799092 (Pubitemid 28470088)
39. F Takeuchi Y Ochiai M Serizawa K Yanai N Kuzuya H Kajio S Honjo N Takeda Y Kaburagi K Yasuda S Shirasawa T Sasazuki N Kato 2008 Search for type 2 diabetes susceptibility genes on chromosomes 1q, 3q and 12q J Hum Genet 53 314 324 10.1007/s10038-008-0254-6 10.1007/s10038-008-0254-6 1:CAS:528: DC%2BD1cXktV2iu7w%3D 18259684
40. JA Condra H Neibergs W Wei MD Brennan 2007 Evidence for two schizophrenia susceptibility genes on chromosome 22q13 Psychiatr Genet 17 292 298 10.1097/YPG.0b013e3281ac2345 10.1097/YPG.0b013e3281ac2345 17728668 (Pubitemid 47345751)
41. SR Archacki G Angheloiu XL Tian FL Tan N DiPaola GQ Shen C Moravec S Ellis EJ Topol Q Wang 2003 Identification of new genes differentially expressed in coronary artery disease by expression profiling Physiol Genomics 15 65 74 1:CAS:528:DC%2BD2cXjvVOnsLw%3D 12902549
42. HP Kohler MH Stickland N OsseiGerning A Carter H Mikkola PJ Grant 1998 Association of a common polymorphism in the factor XIII gene with myocardial infarction Thromb Haemost 79 8 13 1:CAS:528:DyaK1cXmvVylsw%3D%3D 9459313
43. RF Franco PH Reitsma D Lourenco, et al. 1999 Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis Thromb Haemost 81 676 679 1:CAS:528:DyaK1MXjtFOgur0%3D 10365735
44. U Wartiovaara M Perola H Mikkola, et al. 1999 Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males Atherosclerosis 142 295 300 10.1016/S0021-9150(98)00241-X 10.1016/S0021-9150(98) 00241-X 1:CAS:528:DyaK1MXivVWitg%3D%3D 10030380 (Pubitemid 29059487)
45. HP Kohler RA Ariens P Whitaker PJ Grant 1998 A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity Thromb Haemost 80 704 1:CAS:528:DyaK1cXms1ahsbw%3D 9798996
46. R Anwar L Gallivan SD Edmonds AF Markham 1999 Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity Blood 93 897 905 1:CAS:528:DyaK1MXpsFyisw%3D%3D 9920838
47. S Kangsadalampai PG Board 1998 The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity Blood 92 2766 2770 1:CAS:528:DyaK1cXms1eltL8%3D 9763561
48. WY Almawi G Ameen H Tamim RR Finan N Irani-Hakime 2004 Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease J Thromb Thrombolysis 17 199 205 10.1023/B:THRO.0000040489.86029.27 10.1023/B:THRO. 0000040489.86029.27 1:CAS:528:DC%2BD2cXntleku7s%3D 15353918 (Pubitemid 39193987)
49. N Bennouar A Allami H Azeddoug A Bendris A Laraqui A El Jaffali N El Kadiri R Benzidia A Benomar S Fellat M Benomar 2007 Thermolabile Methylenetetrahydrofolate Reductase C677T Polymorphism and Homocysteine Are Risk Factors for Coronary Artery Disease in Moroccan Population J Biomed Biotechnol 2007 1 80687 17497026
50. JL Anderson GJ King MJ Thomson M Todd TL Bair JB Muhlestein JF Carlquist 1997 A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction J Am Coll Cardiol 30 1206 1211 10.1016/S0735-1097(97)00310-0 10.1016/S0735-1097(97)00310-0 1:STN:280:DyaK1c%2FhtVequw%3D%3D 9350916 (Pubitemid 27501436)
51. J Ma MJ Stampfer CH Hennekens P Frosst J Selhub J Horsford MR Malinow WC Willett R Rozen 1996 Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians Circulation 94 2410 2416 1:STN:280:DyaK2s%2FotVCgtA%3D%3D 8921781
52. YZ Zheng J Tong XP Do XQ Pu BT Zhou 2000 Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population Br J Haematol 109 870 874 10.1046/j.1365-2141.2000.02112.x 10.1046/j.1365-2141.2000.02112.x 1:CAS:528:DC%2BD3cXmsl2qsb8%3D 10929044 (Pubitemid 30609771)
53. ES Brilakis PB Berger KV Ballman R Rozen 2003 Methylenetetrahydrofolate reductase (MTHFR) 677C > T and methionine synthase reductase (MTRR) 66A > G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid Atherosclerosis 168 315 322 10.1016/S0021-9150(03)00098-4 10.1016/S0021-9150(03) 00098-4 1:CAS:528:DC%2BD3sXksVOku74%3D 12801615 (Pubitemid 36703331)
54. N Martinelli E Trabetti M Pinotti O Olivieri M Sandri S Friso F Pizzolo C Bozzini PP Caruso U Cavallari S Cheng PF Pignatti F Bernardi R Corrocher D Girelli 2008 Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis PLoS ONE 3 2 e1523 10.1371/journal.pone.0001523 18253477 (Pubitemid 351836676)